Balancing Innovation and Accessibility: EU Health Priorities in Pharma Outsourcing

Exploring strategies for balancing innovation, affordability, and access in outsourced pharma production
Highlighting the importance of transparent procurement processes to ensure fair pricing and quality
Promoting health security by strengthening partnerships with reliable external manufacturing networks
Encouraging investment in innovative therapies addressing unmet needs while ensuring cost-effectiveness
Advancing EU-led initiatives to secure sustainable and resilient pharma supply chains